Story perspectives

Medicare Launches $50 GLP-1 Bridge Pilot July 2026

6/30/2026

Summary

CMS Launches GLP-1

CMS will launch the Medicare GLP-1 Bridge program on July 1, 2026 with a $50 monthly copay.
It covers Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound KwikPen and Foundayo.
Beneficiaries need Part D coverage and BMI >= 35, or lower BMI with comorbidities.
Providers must submit prior authorization showing weight-loss intent.
The pilot runs through December 31, 2027, with coverage ending unless CMS or Congress extends it.

Summary

Humana Processes

Humana will process claims, prior-authorizations, and pharmacy payments for the GLP-1 Bridge, not Part D plans.
KFF analysis of 2023 Part D data estimates about 3.8 million Medicare beneficiaries could qualify.
AARP will disseminate Bridge information and monitor rollout problems enrollees may face.
Extra Help recipients still owe the $50 monthly copay, creating an affordability barrier.
Patients on a GLP-1 drug through Part D must stay in their current plan to avoid coverage disruption.

1 of 2

CMS Launches GLP-1

CMS will launch the Medicare GLP-1 Bridge program on July 1, 2026 with a $50 monthly copay.
It covers Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound KwikPen and Foundayo.
Beneficiaries need Part D coverage and BMI >= 35, or lower BMI with comorbidities.
Providers must submit prior authorization showing weight-loss intent.
The pilot runs through December 31, 2027, with coverage ending unless CMS or Congress extends it.

1 / 2